Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
Clinical trial NCT00540592 · COMPLETED
Trial details
- NCT number
- NCT00540592
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-08
- Primary completion
- 2008-06-10
- Enrollment
- 2007
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.